share_log

昊海生物科技(06826)3月未实施股份回购 已累计回购约134.68万股A股

Haohai Biotechnology (06826) did not implement share repurchases in March and has repurchased a total of about 1.346,800 A-shares

Zhitong Finance ·  Apr 2 10:32

According to the Zhitong Finance App, Haohai Biotechnology (06826) announced the progress of repurchasing the company's A shares through centralized bidding transactions. In March 2024, the company did not implement a share repurchase. As of March 31, 2024, the company has repurchased approximately 1,346,800 A-shares of the company through centralized bidding transactions, accounting for 0.80% of the company's total share capital. The highest transaction price was 113.50 yuan/share, the lowest transaction price was 84.26 yuan/share, and the total transaction amount was approximately RMB 140 million (excluding transaction fees such as stamp duty and transaction commissions).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment